Skip to content
PICO Portalanswers from OpenAlex

Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas

PaperCitations, authors & open-access status

Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas is a paper indexed in PICO Portal from OpenAlex.

How many citations does Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas have?

PICO Portalcitation count

Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas has 68 citations in the OpenAlex counts PICO Portal stores.

When was Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas published?

PICO Portalyear

Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas has 2013 year in the PICO Portal index.

What is the open-access status of Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas?

PICO Portaloa status

Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas has closed oa status in the PICO Portal index.

What is the DOI of Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas?

PICO Portaldoi

The DOI for Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas is on the source record.

What is the PMID of Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas?

PICO Portalpmid

The PMID for Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas is on the source record.

What is the OpenAlex record for Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas?

PICO Portalopenalex

The OpenAlex for Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial